Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
The purpose of the study is to determine whether the addition of Ipilimumab to Etoposide and Platinum therapy will extend the lives of patients with Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) more than Etoposide and Platinum therapy alone.
Checked against the public recordLast updated Jul 8, 2020 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Phase 3
- Sponsor
- Bristol-Myers Squibb
- Interventions being studied
- Biological: Ipilimumab; Biological: Placebo matching Ipilimumab; Drug: Etoposide; Drug: Cisplatin; Drug: Carboplatin
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com. Inclusion Criteria: * Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) * Eastern Cooperative Oncology Group (ECOG) of 0 or 1 Exclusion Criteria: * Prior systemic therapy for lung cancer * Symptomatic Central Nervous System (CNS) metastases * History of autoimmune disease
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Genesis Cancer CenterHot Springs, Arkansas
- Sutter Medical CenterAuburn, California
- UCSD Moores Cancer CenterLa Jolla, California
- University Of Colorado Cancer CenterAurora, Colorado
- Florida Cancer Specialists S.Fort Myers, Florida
- Cancer Specialists, LLCJacksonville, Florida
- Lake City Cancer CareLake City, Florida
- Florida Cancer SpecialistsSt. Petersburg, Florida
- Medical Oncology, LLCAugusta, Georgia
- Quincy Medical GroupQuincy, Illinois
- Presence Medical Group Hematology OncologySkokie, Illinois
- SIU School Of MedicineSpringfield, Illinois
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 8, 2020. Always confirm current availability with the study team.